Comprehensive Companion Diagnostic (CDx) Solutions-Empowering Precision Medicine
In the current grand context of precision medicine, companion diagnostics (CDx) has become a core link connecting innovative drug development and personalized clinical treatment. Companion diagnostics refers to an in vitro diagnostic device (IVD) or imaging tool that provides crucial information for the safe and effective use of corresponding therapeutic products. Its core value lies in identifying patient groups most likely to benefit from specific treatments or excluding those at risk of serious side effects by detecting specific biomarkers. Currently, mainstream companion diagnostic technologies include established platforms such as PCR, NGS, immunohistochemistry (IHC), and FISH for the precise detection of DNA mutations, RNA expression, and protein biomarkers. Meanwhile, emerging technologies such as liquid biopsy and digital PCR are driving their development towards more minimally invasive and sensitive methods. These technologies collectively enable the precise screening of suitable patients for targeted drugs and immunotherapies.
Figure 1 Percentage of FDA-approved companion diagnostic products
(FDA data, produced by Creative Enzymes Diagnostic)
Creative Enzymes-Diagnostics, with decades of experience in diagnostic enzymes, has become a trusted partner in the global biodiagnostics industry. We focus on enabling key downstream segments of companion diagnostics, providing global pharmaceutical and diagnostic companies with high-quality enzyme raw materials, concurrent development services, and customized manufacturing solutions.
Our core value lies in building a technological bridge from core enzymes to complete companion diagnostic kits. By optimizing enzyme performance and improving detection sensitivity and specificity, we help our partners accelerate product development and ensure the reliability and stability of their diagnostic kits. Against the backdrop of the rapid development of precision medicine globally, we remain committed to promoting the innovation and application of companion diagnostic technologies.
Figure 2 Core Capability Modules: A Comprehensive Three-in-One Solution.
(Produced by Creative Enzymes Diagnostic)
The application of companion diagnostics (CDx) technology has rapidly expanded from the core area of precision oncology to multiple key medical fields such as rare diseases, infectious diseases, cardiovascular diseases, and neurological diseases. With our extensive experience in enzymology and diagnostic development capabilities, we provide stable and efficient core enzyme raw materials and customized solutions for various molecular diagnostic platforms. We are focused on supporting our partners in developing accurate and reliable companion diagnostic products to help achieve patient stratification and personalized treatment.
Figure 3 Application Areas
(Produced by Creative Enzymes Diagnostic)
Creative Enzymes-Diagnostics, a subsidiary of the Creative Enzymes Group focusing on the diagnostics field, is committed to providing the global precision medicine industry with high-quality diagnostic enzyme raw materials and complete solutions.
Contact our business development team today to discuss your specific project needs!
